Jupiter Bio

Substantial jump in sales for the March’07 quarter. It registered a record high sale of Rs.38 cr. up 65% compared to last year and net profit rose by 40% to Rs.8.70 cr. For FY07 its sales increased by 30% to Rs.104 cr. and the profit increased by 50% to Rs.25 cr. This leads to an
EPS of Rs.26 on its diluted equity of Rs.9.86 cr. The promoters converted their 10 lakh warrants into equityshares in March 2007 whereas the balance Rs.17.50 lakh warrants have been converted at Rs.146 in April 2007. Hence, its equity stands at Rs.11.61 cr.

The company is further raising Rs.100 cr. through QIP placement and has entered into strategic business alliance with Ranbaxy on peptide pharmaceuticals for the global market. As per the contract, Ranbaxy is taking 14.90% stake, which will further expand its equity.Estimated FY08 with total revenue of rs.180-200 cr. and profit of Rs.42-45 cr.